Literature DB >> 1457403

Characterization of recombinant HIV-1 Tat and its interaction with TAR RNA.

L W Slice1, E Codner, D Antelman, M Holly, B Wegrzynski, J Wang, V Toome, M C Hsu, C M Nalin.   

Abstract

Recombinant HIV-1 Tat (Tat 1-86) has been purified from the cytoplasmic fraction of Escherichia coli without the use of protein denaturants or chaotropic agents. Chloroquine-mediated uptake of the purified protein into cells resulted in transactivation of the HIV LTR promoter. Tat retains 1.64 mol of Zn2+/mol of protein by atomic absorption spectroscopy. Circular dichroism measurements indicated that the structure of recombinant Tat contains 15-20% alpha-helix. Filter binding assays showed that Tat binds to a 63-nucleotide target TAR RNA with a dissociation constant (Kd) of 10 nM at 25 degrees C, 0.05 M ionic strength, pH 7.5, in a 1:1 Tat-TAR RNA stoichiometry. Nonelectrostatic interactions provide the principal source of free energy of association. While the pH optimum occurs over a wide H+ concentration, the salt dependence of Kd indicates formation of a single ion pair. UV-induced protein-RNA cross-linking produced a labeled Tat-TAR RNA adduct, indicating that direct contact occurred between the Tat protein and TAR RNA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1457403     DOI: 10.1021/bi00163a014

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Molecular dynamics simulations on HIV-1 Tat.

Authors:  Sergio Pantano; Mudit Tyagi; Mauro Giacca; Paolo Carloni
Journal:  Eur Biophys J       Date:  2003-11-08       Impact factor: 1.733

2.  A three-hybrid system to detect RNA-protein interactions in vivo.

Authors:  D J SenGupta; B Zhang; B Kraemer; P Pochart; S Fields; M Wickens
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

3.  Nucleolar protein p120 contains an arginine-rich domain that binds to ribosomal RNA.

Authors:  W C Gustafson; C W Taylor; B C Valdez; D Henning; A Phippard; Y Ren; H Busch; E Durban
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

4.  Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.

Authors:  Vitaly A Likhoshvai; Tamara M Khlebodarova; Sergei I Bazhan; Irina A Gainova; Valery A Chereshnev; Gennady A Bocharov
Journal:  BMC Genomics       Date:  2014-12-19       Impact factor: 3.969

5.  NMR structure of a biologically active peptide containing the RNA-binding domain of human immunodeficiency virus type 1 Tat.

Authors:  A Mujeeb; K Bishop; B M Peterlin; C Turck; T G Parslow; T L James
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

6.  Robust growth of human immunodeficiency virus type 1 (HIV-1).

Authors:  Hwijin Kim; John Yin
Journal:  Biophys J       Date:  2005-07-29       Impact factor: 4.033

7.  Endolysosome iron restricts Tat-mediated HIV-1 LTR transactivation by increasing HIV-1 Tat oligomerization and β-catenin expression.

Authors:  Nabab Khan; Peter W Halcrow; Leo K Lakpa; Mohd Rehan; Xuesong Chen; Jonathan D Geiger
Journal:  J Neurovirol       Date:  2021-09-22       Impact factor: 2.643

8.  Inhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitro.

Authors:  M C Hsu; U Dhingra; J V Earley; M Holly; D Keith; C M Nalin; A R Richou; A D Schutt; S Y Tam; M J Potash
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

9.  Ebola virus VP30 is an RNA binding protein.

Authors:  Sinu P John; Tan Wang; Scott Steffen; Sonia Longhi; Connie S Schmaljohn; Colleen B Jonsson
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

10.  Low active loading of cargo into engineered extracellular vesicles results in inefficient miRNA mimic delivery.

Authors:  Dhruvitkumar S Sutaria; Jinmai Jiang; Ola A Elgamal; Steven M Pomeroy; Mohamed Badawi; Xiaohua Zhu; Ryan Pavlovicz; Ana Clara P Azevedo-Pouly; Jeffrey Chalmers; Chenglong Li; Mitch A Phelps; Thomas D Schmittgen
Journal:  J Extracell Vesicles       Date:  2017-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.